Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 27 Feb 2003):

Attitudes of patients with schizophrenia toward placebo-controlled clinical trials.

Full Abstract

BACKGROUND:
Despite the fact that the efficacy of antipsychotic treatment in patients with schizophrenia has been demonstrated in numerous double-blind studies, placebo-controlled studies are still commonly performed. Although much is known about the opinions of professionals concerning this issue, so far nothing is known about the opinions of patients who are most affected by the realization of placebo-controlled clinical trials.

METHOD:
In a cross-sectional study from June 2000 to January 2001, 100 inpatients and outpatients with ICD-10 schizophrenia or schizophreniform disorder were investigated by using a questionnaire specifically developed to survey patients' attitudes concerning possible participation in placebo-controlled clinical trials. Psychopathology and side effects were physician-rated.

RESULTS:
56% of patients would not be willing to participate in a placebo-controlled clinical trial. On the other hand, only about 16% of the patients are against clinical trials in principle. Gender, treatment, severity of psychopathology (Positive and Negative Syndrome Scale), adverse events (UKU Side Effect Rating Scale), and attitude toward medication (Drug Attitude Inventory) had no statistically significant influence on the decision. Most of the patients (76%) stated that they would not lose trust in their physician if asked to participate in a placebo-controlled clinical trial.

CONCLUSION:
The opinions and fears of patients who are most affected by the debate need to be considered when deciding whether a placebo-controlled clinical trial is necessary.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Hummer, Martina (M); Holzmeister, Roswitha (R); Kemmler, Georg (G); Eder, Ursula (U); Hofer, Alex (A); Kurzthaler, Ilsemarie (I); Oehl, Maria (M); Weiss, Elisabeth (E); Fleischhacker, W Wolfgang (WW);

Affiliation: Department of Biological Psychiatry, Innsbruck University Clinics, Innsbruck, Austria. martina.hummer@uibk.ac.at

Journal and publication information

Publication Type: Comparative Study; Journal Article

Journal: The Journal of clinical psychiatry (J Clin Psychiatry), published in United States. (Language: eng)

Reference: 2003-Mar; vol 64 (issue 3) : pp 277-81

Dates: Created 2003/04/28; Completed 2003/05/09; Revised 2007/11/15;

PMID: 12716268, status: MEDLINE (last retrieval date: 11/6/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Antipsychotic Agents (0) ; Placebos (0)

Related articles

This article has not been indexed for related articles as yet, however you can still use the live related article search links below.

See 100+ related articles.

See a large map of 100+ related articles.

© Advanogy.com 2003-2008 - All rights reserved. Terms of Use | Contact Us | Index